Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246426 · ClinicalTrials.gov registry record · NA
Treatment of Social Cognition in Schizophrenia Trial
A NA study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT02246426: Completed NA study, sponsored by Posit Science Corporation.
NCT02246426 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 149 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246426, a NA study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
This study is a multi-site, prospective, parallel arm, double-blind, randomized, controlled clinical trial to assess the efficacy of an experimental software program targeting social cognitive abilities versus a computer-based software control. Both the study and the software being investigated meet the criteria of Non-Significant Risk.
Primary Outcome
The a priori co-primary social cognitive outcome measure will be a composite score comprised of the following standardized, validated set of assessments: * Penn Emotion Recognition Test (ER40) - A test for visual emotion perception; total percent correct. * Prosody Identification (PROID) - A test for prosody identification; total percent correct. * Penn Facial Memory Test (PFMT) -Immediate recall. A test for immediate recall of faces; total percent correct. * Penn Facial Memory Test (PFMT) - De
Interventions
- OTHER Commercially available computerized training
- OTHER Computerized plasticity-based adaptive cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-08-30 |
| Phase | NA |
What the finished NCT02246426 record still lists
NCT02246426 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Commercially available computerized training is the first listed.
NCT02246426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02246426 about?
NCT02246426 is a clinical study titled "Treatment of Social Cognition in Schizophrenia Trial". This study is a multi-site, prospective, parallel arm, double-blind, randomized, controlled clinical trial to assess the efficacy of an experimental software program targeting social cognitive abilities versus a computer-based software control. Both the study and the software being investigated meet...
What is the current status of trial NCT02246426?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2015-03. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT02246426?
The interventions under investigation include: Commercially available computerized training (OTHER), Computerized plasticity-based adaptive cognitive training (OTHER).
Who is sponsoring clinical trial NCT02246426?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02246426's enrollment target sits among peer trials
149 702nd of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia